Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-09-30

Clinical Trial Update: Sugammadex vs Neostigmine Reversal in Pediatric Appendectomy [Phase 4]

View source ↗

Summary

Phase 4 trial comparing sugammadex with neostigmine for reversal in pediatric appendectomy was terminated, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Neostigmine (neostigmine)
  • Sugammadex (sugammadex)

Snippet

Sponsor: Emory University | Conditions: Appendicitis, Surgery | Phase 4 | Status: TERMINATED | Results posted: 2025-09-30